Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Titel:
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Auteur:
van Lunzen, Jan Maggiolo, Franco Arribas, José R Rakhmanova, Aza Yeni, Patrick Young, Benjamin Rockstroh, Jürgen K Almond, Steve Song, Ivy Brothers, Cindy Min, Sherene